- UroToday Home
- Recent Abstracts
- Urologic Oncology
Prostate Cancer
Population-based study of predictors for adverse pathology among candidates for active surveillance with Gleason 6 prostate cancer - Abstract
October 25, 2013
Changing presentation of prostate cancer in a UK population - 10 Year trends in prostate cancer risk profiles in the East of England - Abstract
October 25, 2013
Comparison of PET imaging with a (68)Ga-labelled PSMA ligand and (18)F-choline-based PET/CT for the diagnosis of recurrent prostate cancer - Abstract
October 25, 2013
Lack of association between COX-2 staining level and biochemical recurrence following salvage radiation therapy for recurrent prostate cancer - Abstract
October 25, 2013
Social epidemiology: A tool for examining prostate cancer early-detection decision making among older African American men - Abstract
October 25, 2013
Estimation of rectal dose using daily megavoltage cone-beam computed tomography and deformable image registration - Abstract
October 25, 2013
The impact of supportive nursing care on the needs of men with prostate cancer: A study across seven European countries - Abstract
October 25, 2013
Bone-targeted therapies in metastatic castration-resistant prostate cancer: Evolving paradigms - Abstract
October 25, 2013
Pathological and oncological outcomes of elderly men with clinically localized prostate cancer - Abstract
October 24, 2013
Positive surgical margins at radical prostatectomy: Population-based averages within PSA and Gleason strata - Abstract
October 24, 2013
Needle biopsy size and pathological Gleason score diagnosis: No evidence for a link - Abstract
October 24, 2013
Stereotactic body radiotherapy in prostate cancer: Is Rapidarc a better solution than Cyberknife? - Abstract
October 24, 2013
Safety of abiraterone acetate in castration-resistant prostate cancer patients with concomitant cardiovascular risk factors - Abstract
October 24, 2013
Urologists' use of intensity-modulated radiation therapy for prostate cancer - Abstract
October 24, 2013